Versor Investments LP Buys New Shares in Danaher Corporation $DHR

Versor Investments LP bought a new stake in Danaher Corporation (NYSE:DHR) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 2,668 shares of the conglomerate’s stock, valued at approximately $527,000.

Several other hedge funds and other institutional investors have also made changes to their positions in DHR. Pacific Capital Partners Ltd purchased a new stake in shares of Danaher during the 1st quarter worth $7,175,000. Concurrent Investment Advisors LLC lifted its position in shares of Danaher by 193.2% during the 1st quarter. Concurrent Investment Advisors LLC now owns 10,048 shares of the conglomerate’s stock worth $2,060,000 after purchasing an additional 6,621 shares during the last quarter. Envestnet Asset Management Inc. lifted its holdings in Danaher by 14.1% during the 1st quarter. Envestnet Asset Management Inc. now owns 1,261,196 shares of the conglomerate’s stock worth $258,545,000 after buying an additional 155,537 shares during the last quarter. Stratos Wealth Advisors LLC lifted its holdings in Danaher by 13.1% during the 1st quarter. Stratos Wealth Advisors LLC now owns 15,707 shares of the conglomerate’s stock worth $3,220,000 after buying an additional 1,817 shares during the last quarter. Finally, Personal CFO Solutions LLC lifted its holdings in Danaher by 5.5% during the 1st quarter. Personal CFO Solutions LLC now owns 3,654 shares of the conglomerate’s stock worth $749,000 after buying an additional 189 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

Several research firms recently weighed in on DHR. Redburn Partners set a $220.00 target price on Danaher in a research note on Wednesday, October 8th. Cowen reissued a “buy” rating on shares of Danaher in a report on Wednesday, October 22nd. Robert W. Baird set a $247.00 price objective on Danaher in a research note on Wednesday, October 22nd. Guggenheim reiterated a “buy” rating and issued a $250.00 price objective on shares of Danaher in a research note on Wednesday, July 23rd. Finally, JPMorgan Chase & Co. boosted their price objective on Danaher from $260.00 to $270.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Eighteen investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, Danaher currently has an average rating of “Moderate Buy” and an average target price of $243.39.

Danaher Price Performance

Danaher stock opened at $213.89 on Wednesday. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $258.23. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10. The business has a 50 day simple moving average of $203.68 and a 200-day simple moving average of $199.98. The stock has a market capitalization of $151.08 billion, a PE ratio of 44.10, a price-to-earnings-growth ratio of 3.28 and a beta of 0.77.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, October 21st. The conglomerate reported $1.89 EPS for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. The company had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. Danaher had a net margin of 14.44% and a return on equity of 10.92%. Danaher’s quarterly revenue was up 4.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.71 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, October 31st. Investors of record on Friday, September 26th were issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend was Friday, September 26th. Danaher’s dividend payout ratio is currently 26.39%.

Insider Activity

In other news, Director Teri List sold 2,778 shares of the stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the transaction, the director directly owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 11.10% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.